Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.

[1]  S B Rosalki,et al.  BIOCHEMICAL MARKERS OF BONE TURNOVER , 1998, International journal of clinical practice.

[2]  T. Schilling,et al.  The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease. , 1995, The Journal of clinical endocrinology and metabolism.

[3]  R. Coleman.  Evaluation of bone disease in breast cancer , 1994 .

[4]  J. Risteli,et al.  Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. , 1993, Clinical chemistry.

[5]  R. Talamini,et al.  Biochemical markers for detecting bone metastases in patients with breast cancer. , 1993, Clinical chemistry.

[6]  D. Eyre,et al.  A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. , 1991, British journal of cancer.

[8]  N. Clarke,et al.  Morphometric evidence for bone resorption and replacement in prostate cancer. , 1991, British journal of urology.

[9]  G. Mundy.  Mechanisms of osteolytic bone destruction. , 1991, Bone.

[10]  A. F. Stewart,et al.  Clinical review 16: Parathyroid hormone-related proteins: coming of age in the 1990s. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  J. Risteli,et al.  Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. , 1990, Clinical chemistry.

[12]  J. Cabranes,et al.  Hyperparathyroidism in metastases of prostatic carcinoma: a biochemical, hormonal and histomorphometric study. , 1990, European urology.

[13]  D. Uebelhart,et al.  Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. , 1990, Bone and mineral.

[14]  J. Riancho,et al.  The clinical spectrum of hypocalcaemia associated with bone metastases , 1989, Journal of internal medicine.

[15]  A. Paterson.  Bone metastases in breast cancer, prostate cancer and myeloma. , 1987, Bone.

[16]  J. Kanis,et al.  Generalised increase in bone resorption in carcinoma of the prostate. , 1985, British journal of urology.

[17]  R. L. Carter.  Patterns and mechanisms of bone metastases. , 1985, Journal of the Royal Society of Medicine.

[18]  S. Jacobs.  Spread of prostatic cancer to bone. , 1983, Urology.

[19]  R. Blamey,et al.  Calcium excretion (CaE) in metastatic breast cancer , 1983, The British journal of surgery.